Catalyst Wire Dossier Catalyst Wire Dossier

Insulin NNC0471-0119 H

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Insulin NNC0471-0119 H, covering 2026-04-07 to 2026-04-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test How Insulin NNC0471-0119 H Works in the Body in Participants With Type 2 Diabetes When Given by an Insulin Pump [Phase 1]

See pricing